Li Ding
- Genetics top 5%
- Mesenchymal stem cell research 21
- Cancer Research top 10%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 5
- Reproductive Medicine top 5%
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 21
- Acute Myeloid Leukemia Research 6
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 7
- RNA Interference and Gene Delivery 6
- RNA Research and Splicing 6
Li Ding
77 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Genetics 204
- Cancer Research 263
- Reproductive Medicine 127
- Hematology 151
- Molecular Biology 713
Countries citing papers authored by Li Ding
This map shows the geographic impact of Li Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ding more than expected).
Fields of papers citing papers by Li Ding
This network shows the impact of papers produced by Li Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ding. The network helps show where Li Ding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 21 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 19 | |
| 10 | 2017 | 5 | |
| 11 | 2017 | 23 | |
| 12 | 2017 | 14 | |
| 13 | 2016 | 36 | |
| 14 | 2015 | 15 | |
| 15 | 2015 | 20 | |
| 16 | 2014 | 23 | |
| 17 | 2014 | 32 | |
| 18 | 2014 | 26 | |
| 19 | 2013 | 13 | |
| 20 | 2011 | 9 |
About Li Ding
Li Ding is a scholar working on Genetics, Hematology and Cancer Research, having authored 80 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (21 papers), Mesenchymal stem cell research (21 papers), MicroRNA in disease regulation (8 papers), CRISPR and Genetic Engineering (7 papers), RNA Interference and Gene Delivery (6 papers), Acute Myeloid Leukemia Research (6 papers), RNA Research and Splicing (6 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Genetics (204 citations), Cancer Research (263 citations) and Reproductive Medicine (127 citations). Li Ding has collaborated with scholars based in China, Germany and Denmark. Frequent co-authors include Frank Buchholz, Wanchun Wang, Maciej Paszkowski‐Rogacz, Changjun Zeng, Heng Zhu, Xiao-Li Zheng, Hong-Min Yan, Ning Mao, Herbert Schulz and Yan Zhang. Their work appears in journals such as Stem Cell Research & Therapy, PLoS ONE, Stem Cells Translational Medicine, Cryobiology and Life Science Alliance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.